Diverticular Disease Clinical Trial
Official title:
Prophylactic Elective Clipping of Colonic Diverticula in Patients Who Have Had Sustained Lower Gastrointestinal Haemorrhage
Diverticular bleeding is the most common cause of acute lower gastrointestinal bleeding
(LGIB) in Western populations. Although self-limited in 85% of cases, some patients may
require hospitalization with blood transfusion and emergent intervention, with significant
associated morbidity and mortality. Up to 25% of patients with an initial bleeding episode
will have subsequent episodes.
Diverticula form at weak points along the colon wall, where the vasa recta enter the circular
muscle layer of the colon. Diverticular bleeding is attributed to thinning of the blood
vessels as they cross over the dome of a diverticulum. Endoscopic clipping of actively
bleeding colonic diverticula has been recognized as a safe and effective treatment for acute
LGIB since the mid1990s. Patients selected would have had previous colonoscopy to exclude
other causes of bleeding (e.g. angiodysplasia, colorectal cancer).
The investigators propose prophylactic elective endoscopic diverticular clipping in patients
who have had at least 1 episode of acute LGIB requiring hospitalization. This would involve
applying endoscopic clips to the base of every diverticula in a patient's colon, such that
any bleeding source would effectively be excluded. The investigators would later reevaluate
patients for colonoscopic appearance of diverticula to assess their diverticular disease.
The investigators hypothesize that patients undergoing endoscopic diverticular clipping will
not have repeat episodes of bleeding.
1.0 BACKGROUND AND HYPOTHESES
The investigators aim to prophylactically clip all colonic diverticula in patients who have
experienced at least 1 episode of diverticular bleeding requiring hospitalization, but
without definitive procedure (i.e., total colectomy or localization with embolization or
clipping). The investigators' objective is to prevent future episodes of colonic bleeding
from the diverticula, so as to avoid morbidity and possible mortality.
The investigators hypothesize that those patients undergoing secondary prophylaxis through
diverticular clipping will experience no further episodes of diverticular bleeding.
2.0 OBJECTIVES AND PURPOSE
Diverticular bleeding is the most common cause of acute lower gastrointestinal bleeding
(LGIB) in Western populations. Although self-limited in 85% of cases, some patients may
require hospitalization with blood transfusion and emergent intervention, with significant
associated morbidity and mortality. Up to 25% of patients with an initial bleeding episode
will have subsequent episodes.
Diverticula form at weak points along the colon wall, where the vasa recta enter the circular
muscle layer of the colon. Diverticular bleeding is attributed to thinning of the blood
vessels as they cross over the dome of a diverticulum. Endoscopic clipping of actively
bleeding colonic diverticula has been recognized as a safe and effective treatment for acute
LGIB since the mid-1990s. Patients selected would have had previous colonoscopy to exclude
other causes of bleeding (e.g. angiodysplasia, colorectal cancer).
The investigators propose prophylactic elective endoscopic diverticular clipping in patients
who have had at least 1 episode of acute LGIB requiring hospitalization. This would involve
applying endoscopic clips to the base of every diverticula in a patient's colon, such that
any bleeding source would effectively be excluded. The investigators would later re-evaluate
patients for colonoscopic appearance of diverticula, as there is some suggestion that
diverticula may resolve after such management.
3.0 STUDY DESIGN
The investigators propose a prospective feasibility study of outpatients who have previously
been hospitalized with at least one episode of diverticular bleeding. Diverticular disease
will have been confirmed by previous colonoscopy to assess the extent of diverticular
disease. Consecutive patients at follow-up outpatient appointments will be approached with a
Patient Information Sheet. On follow-up appointment they will be recruited and enrolled for
endoscopic clipping of colonic diverticula.
The procedure itself will be similar to a screening colonoscopy. As outpatients, patients
will take bowel preparation. Colonoscopy will occur with sedation only, including fentanyl
and midazolam per protocol. Individual colonic diverticula will be clipped to exclude the
bleeding source.
Twenty-four (24) patients will be enrolled for diverticular clipping. These patients will be
followed prospectively for 2 years for repeat bleeding episodes. Follow-up will consist of
telephone calls every 6 months by the study team. In addition, patients will be scheduled for
repeat colonoscopy to assess their diverticular disease 6 months after clipping of colonic
diverticula.
4.0 SELECTION AND WITHDRAWAL OF SUBJECTS Currently, patients admitted with complications of
diverticular disease are seen in Diverticular Disease clinic for follow-up. Consecutive
patients will be selected from this patient population.
Patients may withdrawal from the study at any time, including during the colonoscopy with
clipping of diverticula.
5.0 DATA COLLECTION AND MONITORING
Data collection will take place on a specially created case report form (See case report form
version 1.2). Case report forms will be stored in a locked office in the Department of
Colorectal Surgery accessible only to the study team. Data will be entered into an excel
spreadsheet. The spreadsheet will be kept on a password protected NHS desktop in a locked
office in the Department of Colorectal Surgery.
6.0 STATISTICAL CONSIDERATIONS
As this is a feasibility study, recruited patients will be study prospectively. Any analysis
will include all patients enrolled. There will be no control group or randomization at this
time.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03935100 -
Prophylactic Endoscopic Clipping of Diverticula (PECoD)
|
N/A | |
Completed |
NCT01120340 -
Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares
|
Phase 3 | |
Recruiting |
NCT02598414 -
The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery
|
Phase 2/Phase 3 | |
Completed |
NCT02068482 -
Immunohistology in USDD and Correlation Between Bacterial Flora and Phlogosis
|
Phase 4 | |
Completed |
NCT04173182 -
Confocal Laser Endomicrospy in Colonic Diverticular Disease
|
||
Completed |
NCT02849717 -
Pre-Habilitation Exercise Intervention
|
N/A | |
Withdrawn |
NCT02221713 -
The Gut Microbiome in Diverticulitis and Diverticulosis
|
||
Recruiting |
NCT03490279 -
Lactoferrin for the Treatment of Symptomatic Uncomplicated Diverticular Disease
|
N/A | |
Recruiting |
NCT02500992 -
Bacterial Contamination in Transrectal Hybrid NOTES Sigmoidectomy
|
N/A | |
Recruiting |
NCT01626963 -
Single-port Versus Conventional Laparoscopic Colorectal Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT02278770 -
DD Obesity MRI Study
|
N/A | |
Recruiting |
NCT00747292 -
Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT02115867 -
Effect of a Probiotic on Diverticular Symptoms
|
Phase 3 | |
Terminated |
NCT03455751 -
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
|
N/A |